MENU CONTENTS

Stem Cell Drugs

Breaking the Barrier of Incurable Diseases with the Successful Commercialization of the World’s First Allogeneic Stem Cell Drug

Stem Cells, the Future of Biotechnology

Stem cells are undifferentiated cells with the ability to develop intovarious cells or tissues. The cells can restore damaged body functions through self-renewal, differentiation and/or the secretion of various cell-derived factors into the environment of defect area.


The Healing Power of Newborn Cells,MEDIPOST’s Cord Blood Stem Cell Drugs

The strong therapeutic potential of stem cell products developed by MEDIPOST comes from the human Umbilical Cord Blood-derived Mesenchymal Stem Cells (hUCB-MSCs), the most natural source of life. Umbilical cord blood is the blood found in the umbilical cord of a newborn and is the source of the purest stem cells. hUCB-MSCs retain the highest vitality and regenerative capacity among all types of adult stem cells and deliver highly efficacious and safe clinical results.

  • 카티스템

    CARTISTEM®
    Treatment of knee cartilage defects in patients with Osteoarthritis (ICRS grade IV)
    caused by degeneration or repetitive trauma
  • 뉴모스템

    PNEUMOSTEM®
    Preventative treatment of Bronchopulmonary Dysplasia
  • 뉴로스템

    NEUROSTEM®
    Preventive treatment of Alzheimer’s disease

상단으로